Expert Speaker Faculty

Large Pharma Speakers:

Bidisha Dasgupta

Director, Immunology Scientific Licensing

Johnson & Johnson

Nikhil Mutyal - 3rd Cell Therapy for Autoimmune Disease Summit

Nikhil Mutyal

Head, Respiratory, Immunology, Search & Evaluation

AstraZeneca

Susanne Diehl - 3rd Cell Therapy for Autoimmune Disease Summit

Susanne Diehl

Head, Global Program & Immunology

Novartis AG

Innovative Biotech Leaders:

Adil Duru - 3rd Cell Therapy for Autoimmune Disease Summit

Adil Doganay Duru

Director - Business Development

Glycostem Therapeutics

Christopher Tehlarian - 3rd Cell Therapy for Autoimmune Disease Summit

Chris Tehlirian

Executive Medical Director

Legend Biotech

Chris Jewell - 3rd Cell Therapy for Autoimmune Disease Summit

Christopher Jewell

Chief Scientific Officer

Cartesian Therapeutics

Clinton Weber - 3rd Cell Therapy for Autoimmune Disease Summit

Clinton Weber

Vice President, CMC Strategy

Umoja Biopharma

Dan Shelly - 3rd Cell Therapy for Autoimmune Disease Summit

Dan Shelly

Chief Business Development Officer

PolTREG Immuthera

Ed Zhang - 3rd Cell Therapy for Autoimmune Disease Summit

Ed Zhang

Co-Founder & Chief Executive Officer

Overland Pharmaceuticals

Fred Aslan - 3rd Cell Therapy for Autoimmune Disease Summit

Fred Aslan

President & Chief Executive Officer

Artiva Biotherapeutics, Inc

Gilles Besin - 3rd Cell Therapy for Autoimmune Disease Summit

Gilles Besin

Chief Scientific Officer

Orbital Therapeutics, Inc.

Jenell Volkov - 3rd Cell Therapy for Autoimmune Disease Summit

Jenell Volkov

Senior Director - Translational Medicine

Cabaletta Bio

Jennifer Bush - 3rd Cell Therapy for Autoimmune Disease Summit

Jennifer Bush

Chief Operating Officer

Artiva Biotherapeutics, Inc

Jennifer Chow - 3rd Cell Therapy for Autoimmune Disease Summit

Jennifer Chow

Chief Executive Officer

iCell Gene Therapeutics

Jim Sesic - 3rd Cell Therapy for Autoimmune Disease Summit

Jim Sesic

SVP, Regulatory Affairs

Atara Biotherapeutics Inc.

Laurie Beitz - Umoja Biopharma

Laurie Beitz MD

Senior Director, Discovery

Umoja Biopharma

Luke Devey - 3rd Cell Therapy for Autoimmune Disease Summit

Luke Devey

Chief Medical Officer

Quell Therapeutics

Mark Back - 3rd Cell Therapy for Autoimmune Disease Summit

Mark Bach

Chief Medical Officer

GentiBio

Phung Gip - 3rd Cell Therapy for Autoimmune Disease Summit

Phung Gip

Senior Director & Head of Translational Medicine

Nkarta, Inc.

Samik Basu - 3rd Cell Therapy for Autoimmune Disease Summit

Samik Basu

Chief Scientific Officer

Cabaletta Bio

Shawn Rose- 3rd Cell Therapy for Autoimmune Disease Summit

Shawn Rose

Chief Medical Officer & Head of Research & Development

Nkarta Therapeutics

Teresa Whalen - 3rd Cell Therapy for Autoimmune Disease Summit

Teresa Whalen

Chief Executive Officer

CytoAgents

Timmothy Taps - 3rd Cell Therapy for Autoimmune Disease Summit

Timmothy Taps

Senior Director, Regulatory Affairs, Head of Regulatory Strategy & Operations

Century Therapeutics

Warren Li

Senior Vice President, Head of Preclinical Research & Project Leadership

Overland Therapeutics

Academic & Expert KOLs:

Asal Shirazi BEM

Founder & Chief Executive Officer

Autoimmune Support & Awareness

Patricia Beaston - 3rd Cell Therapy for Autoimmune Disease Summit

Patricia Beaston

Independent Consultant

Former FDA (2000-2024)

What Our Experts Have to Say:

A very valuable opportunity to connect with and hear from the latest and greatest in the field

President & Chief Executive Officer, Artiva Biotherapeutics, 2025 Speaker

Artiva Biotherapeutics - 3rd Cell Therapy for Autoimmune Disease Summit

This is a unique summit that brings together leaders in the field who are committed to developing groundbreaking therapies for patients with immune-mediated diseases

Chief Medical Officer, Nkarta Therapeutics, 2025 Speaker

Nkarta Therapeutics - 3rd Cell Therapy for Autoimmune Disease Summit

Partner With Us